Boston Scientific Stock Forecast
NYSE: BSXHealthcareMedical DevicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 41.59 +0.05%
BSX analyst consensus
Consensus (31 analysts)
buy
Avg. price target
$59.90+44.06%
- Strong buy 7
- Buy 18
- Hold 6
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 31 Wall Street analysts covering Boston Scientific (2026-10-08), 25 rate the stock a buy or strong buy, 6 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $59.90, with a high estimate of $94.00 and a low estimate of $44.00. The average target implies upside of 44.1% from the current price of $41.58.
The spread between the highest and lowest targets is 113.6%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for BSX.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 7 | 23% |
| Buy | 18 | 58% |
| Hold | 6 | 19% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $44.00 | +5.82% |
| Average target | $59.90 | +44.06% |
| High target | $94.00 | +126.07% |